v3.25.1
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Stock Options Activity

The following table sets forth the activity of the options to purchase common stock under the 2019 Plan.

 

 

  

Number of

Shares

  

Weighted

Average

Exercise

Price

  

Aggregate

Intrinsic

Value

 
Outstanding as of December 31, 2024   8,192   $422.05   $- 
Granted   -    -    - 
Exercised   -    -    - 
Canceled   (2,023)   770.50    - 
Balance as of March 31, 2025   6,169   $415.11   $- 
Exercisable as of March 31, 2025   8,244   $581.87   $- 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

The fair value of each option granted is estimated as of the grant date using the Black-Scholes option pricing model with the following assumptions:

 

  

Three months ended

March 31,

 
   2025   2024 
Risk-free interest rate range   -%   3.95%
Expected life of option-years   -    5.50 
Expected stock price volatility   -%   150%
Expected dividend yield   -%   -%
Schedule of Share Based Payments Arrangements Options Exercised and Options Vested

  

Total

Intrinsic

Value of

Options

Exercised

  

Total Fair

Value of
Options

Vested

 
Year ended December 31, 2024  $-   $278,406 
Three months ended March 31, 2025  $-   $209,371